Not registered yet? Please contact our project manager Dr. Mary Gazea . This area is only for members of the research consortium.

We report to YOU

This section keeps you updated on any major developments throughout the course of the DECISION project. For PDFs of our own press releases please go to DOWNLOADS. To receive our project newsletter please subscribe here!

  • 25 October 2022

    Opening of the 2022/2023 academic year of the Master in Bioethics and Law: Practical lecture on bioethical aspects in biomedical research projects funded by the European Union’s Horizon 2020 programme, taught by Itziar de Lecuona

    The opening of the 2022/2023 academic year of the University of Barcelona’s Master in Bioethics and Law will take place on October 25, 2022.

    Dr. Itziar de Lecuona, associate professor of the Department of Medicine, director of the Bioethics and Law Observatory and co-director of the Master in Bioethics and Law at the University of Barcelona, will give a practical lecture on bioethical aspects in biomedical research projects funded by the European Union’s Horizon 2020 programme.

    This session will be held exclusively for new students of the Master in Bioethics and Law, and for researchers and doctoral students from the Bioethics and Law Observatory.

    It will allow the attendees to identify which contributions they could provide from bioethics, based on their profile and knowledge, in the different phases of the project, within the framework of the respective Work Packages on “Ethics, Health and Socioeconomics”. It will intend to train and improve their skills in bioethics in the field of research ethics, scientific integrity and responsible research and innovation.

    More information.

  • 21 October 2022

    Free access to EASL educational tools for our early career scientists

    We are grateful about a great opportunity for all DECISION early-career scientists (ECS) to benefit from EASL’s extensive educational tools and our Young Investigators (YI) community.EASL campus is currently open access for those individuals with a MyEASL account. In the coming months, some of the content will be restricted to EASL Members. Therefore, EASL invites the project’s ECS to create a MyEASL account and request a complimentary membership. Do not hesitate to reach out to the PMO if you have any questions and more information here.

  • 14 October 2022

    Publication of the infographic based on the document “Guidelines for reviewing health research and innovation projects that use emergent technologies and personal data”!

    The infographic based on the document “Guidelines for reviewing health research and innovation projects that use emergent technologies and personal data”, published by the Bioethics and Law Observatory – UNESCO Chair in Bioethics of the University of Barcelona and coordinated by Dr. Itziar de Lecuona, was presented within the framework of the seminar “Artificial intelligence and data protection in health research and innovation: ethical, legal and social aspects”, on September 21, 2022.

    Dr. Itziar de Lecuona, associate professor of the Department of Medicine, director of the Bioethics and Law Observatory and co-director of the Master in Bioethics and Law at the University of Barcelona, showed the infographic, which synthesizes and highlights the essential points developed in the document, during her lecture “Research ethics committees and data protection in the evaluation of emerging technologies in health research and innovation”.

    In this way, the infographic exposes, in a visual and concise way, what Research Ethics Committees (RECs) are, their functions, and the dilemmas that health research and innovation projects raise, especially in a scenario where emerging technologies and the exploitation of personal data play a leading role.

    The infographic presents the challenges that Research Ethics Committees (RECs) must face (avoid the Europe’s excessive dependence on the American tech companies, update the obsolete protocols for obtaining informed consent, etc.); and lists a series of recommendations so that RECs can perform their functions correctly and efficiently, with the support of both research and innovation centres and legislators, to guarantee the protection of the rights of individuals in projects that use emerging technologies, such as artificial intelligence, big data, biometrics, and/or virtual reality.

  • 30 September 2022

    Checklist for participants to assure informed consent / other mechanisms for those unable to give a written consent

    Use our new checklist to assure informed consent for medical research! It facilitates compliance with legal and ethical guidelines related to research involving humans, use of biological samples, and/or personal data.  Read more.

  • 23 September 2022

    Watch our mini-video series from #ILC2022

    Following the patients’ interest in DECISION, we tried something new during the International Liver Congress (ILC) in London in June 2022, namely recording several video interviews by representatives of the European Liver Patients’ Association (ELPA) with our scientific coordinator Prof. Dr. Pierre-Emmanuel Rautou. And because we were on a roll, the new concentris team member Dennis Cleff also interviewed Prof. Dr. Sara Montagnese (UNIPD) about the symptoms of decompensated cirrhosis via Zoom shortly thereafter. Watch all videos here.

  • 21 September 2022

    Bioethics and Law Observatory organises an online seminar

    On September 21, 2022, the Bioethics and Law Observatory (OBD) -UNESCO Chair in Bioethics and the Spanish Data Protection Agency (AEPD) jointly organize the seminar “Inteligencia artificial y protección de datos en investigación e innovación en salud: aspectos éticos, legales y sociales”(“Artificial intelligence and data protection in health research and innovation: ethical, legal and social aspects”).

    This seminar is part of an agreement between the Bioethics and Law Observatory (OBD) and the Spanish Data Protection Agency.

    This event is free and open for anyone, but please note that it will be held in Spanish. For more information click here, find here the program and feel free to register here for your online attendance.

  • 14 January 2022

    Liver seminar about extracellular vesicles in cirrhosis

    Watch the latest liver seminar of DECISION coordinator, Prof. Pierre-Emmanuel Rautou, of January, 14th 2022 and learn more about extracellular vesicles in cirrhosis.

    Liver Seminars – January 14th 2022 – YouTube

  • 13 January 2022

    Jonel Trebicka’s Masterclass now on YouTube

    Watch our newest Masterclass by DECISION consortium member Prof. Dr. Jonel Trebicka who also serves as the coordinator of the topically related Horizon 2020 project MICROB-PREDICT. He provides a step-by-step guide on how to write a high-quality scientific paper. Besides fun examples of what to do and not to do, his advice includes reducing complexity, focussing on key results, displaying the distribution of data points, as well as avoiding lengthy introductions, poetic language, or complicated sentences.

  • 14 December 2021

    Paolo Angeli’s Masterclass now on YouTube

    In this Masterclass, invited speaker Prof. Dr. Paolo Angeli, the current editor-in-chief of the Journal of Hepatology, teaches his approach to write a good scientific paper and submit it to the appropriate journal, a process that he compares to the challenge of winning a soccer game. While focussing on concrete advice, he also points out several common mistakes that less experienced authors make, some of which can be easily avoided. How? Watch the video!

  • 29 November 2021

    Submission of first periodic report to European Commission

    Today, the DECISION Consortium submitted the first periodic report to the European Commission. Over a period of more than two months all partners worked hard to report work performed, results and efforts. The PMO thanks all involved people for their great collaboration and diligent work.

  • 03 November 2021

    Theresa Wirtz appointed as new chair of the Early Career Scientists group

    We congratulate Theresa Wirtz from University of Aachen for having been appointed as new chair of the DECISION Early Career Scientists group. She takes this important position over from her predecessor Frank Uschner (GUF) who was the chair in the first year of the project.

    Thanks to Frank for his efforts to coordinate the training activities during the 1st year which included amongst other things the organisation of the 1st masterclass!

  • 27 - 30 October 2021

    BavenoVII Consensus Workshop sponsored by DECISION

    DECISION supports this year`s BavenoVII Consensus Workshop. Baveno Workshops have been held every 5 years from 1990 till today. Each time, important advances have been made in understanding the pathophysiology of portal hypertension, as well as in developing new treatments and new strategies for the management of advanced cirrhosis and portal hypertension. See programme.

  • 09 September 2021

    DECISION Poster Award

    Congratulations to Dr Cristina López-Vicario (Researcher, Fundació Clínic per la Recerca Biomèdica) for winning the first prize of the DECISION Poster Award.

    A total of 8 posters were shown during this year’s poster session at the General Assembly Meeting, on 9th September 2021 in Barcelona/Spain.

    For further information, click here.

  • 19 August 2021

    DECISION: Cirrhosis – Overview of existing therapies, drugs & research needs, Pierre-Emmanuel Rautou

    In this video, the project’s scientific coordinator, Prof. Pierre-Emmanuel Rautou, explains the complications that can occur in cirrhosis patients and how the DECISION project aims to better stratify patients that come to the clinic with acute decompensation (of cirrhosis). The goal is to personalise the treatment of individual patients based on tests that can predict the expected treatment outcome. The video is a recording of the 1st presentation given at an online patient event that was jointly organised by ELPA and EF CLIF and took place on 9th June 2021.

    Watch video on YouTube
  • 09 June 2021

    Successful patient event on 9th June

    27 representatives of national patient organisations from 10 European countries listened to talks about therapies for cirrhosis and ACLF, research needs and outlook for the future. A lot of interest was shown towards available and new therapies for decompensated cirrhosis and ACLF. The event was organised by ELPA (president Marko Korenjak) and chaired by Prof. Rajiv Jalan, scientific director of EF CLIF.

  • 24 June 2021

    ILC 2021: Symposium „Old and new treatments for patients with advanced cirrhosis”

  • 15 April 2021

    DECISION Steering Committee Meeting

    From 14th – 15th April, the DECISION Steering Committee met again fully virtual. 20 participants exchanged information about progress and results. Great achievement: all ACLARA samples, which are relevant for the work of DECISION, now reached the partner labs. Now the work on these samples can start and we cannot wait to see results.

  • 02 March 2021

    Pierre-Emmanuel Rautou is being interviewed by “Science et Vie”

    In its March issue, the French journal for laymen on science “Science et Vie” interviewed DECISION coordinator Pierre-Emmanuel Rautou on the topic of multi-omics and the acceleration of biomedicine. By decoding the hidden information at the heart of our cells, multi-omics is revolutionising many areas of research. Click below to read further [Articles in French]:

    DANS LE SECRET – DES CELLULES LA MULTIO MIQUE (PDF)

    UNE FORMIDABLE ACCÉLÉRATION DE LA BIOMÉDECINE (PDF)

  • 25 November 2020

    Successful virtual General Assembly Meeting

    On 24-25 Nov 2020, 51 members of the DECISION consortium and 4 members of the Scientific and Ethical Advisory Board met online to discuss the progress made during the first 8 months and important next steps. Despite the COVID-19 pandemic, the project is largely on track and important first results have been delivered. Still we all cannot wait to meet in person next time to speed up the communication and international collaboration!

  • 10 September 2020

    Codes of conduct applicable and research integrity policy including publications in journals published

    This document is an analysis of the current codes of good conduct published by each member of the DECISION project: Here, we discuss what is included in the DECISION partners’ code of conduct, any references to national or international guidelines, how easily accessible the relevant information is from the home page and the general usefulness of the document for the members of the institutions themselves and the public.

    Read More
  • 31 August 2020

    Public engagement strategy to design DECISION along with the need of patients finalized

    The goal of this policy is to provide a framework of public engagement in research in DECISION to align this project with the Responsible Research and Innovation (RRI) framework.

    Read More
  • 27 August 2020

    Prof. Dr. Paolo Caraceni from UNIBO, Italy, explains the clinical trial of DECISION

    In this video, Prof. Dr. Paolo Caraceni explains the clinical trial, the predictive and response tests, the project’s approach to best-possible patient stratification, and the expected beneficial outcome of DECISION.

    View video on YouTube
  • 28 July 2020

    DECISION in less than 5 minutes: Prof. Pierre-Emmanuel Rautou explains the project in a brief video

    Take a few minutes to listen to Prof. Pierre-Emmanuel Rautou, the scientific coordinator of DECISION, explain and show to you what the project is all about.

    Watch video on YouTube
  • 27 July 2020

    First Patient Event on 31st Aug 2020!

    SAVE THE DATE: We kindly invite you to the 1st DECISION and ELPA patient event. Our first patient event takes place ONLINE on Monday, August 31st, from 16-17h at Central European Standard Time (CEST). For questions and registration, please contact office@elpa.eu.

    View announcement and programme
  • 27 July 2020

    Important milestones achieved!

    We are happy to report that all ethics approvals for data transfers have been received and 5348 samples from PREDICT and 400 from CANONIC have been sent for analysis to all participating labs. Congratulations WP1 team!

  • 22 July 2020

    ELPA president Marko Korenjak introduces DECISION from the perspective of cirrhosis patients in this video

    In this 3-min-long video, Marko Korenjak, the current president of the European Liver Patients Association (ELPA), who is also a key project partner, introduces the scope and aims of the DECISION project.

    Watch video on YouTube
  • 19 July 2020

    Interleukin-22 in acute-on-chronic liver failure (ACLF): A matter of ineffective levels, receptor dysregulation, or defective signalling?

    Read the new article by Schwarzkopf et al. published in J Hep on 19 July 2020. This work addresses one of the new models used in DECISION: The authors analysed the effects of interleukin 22 (IL-22) in a mouse model of ACLF after chronic carbon tetrachloride (CCl4)-treatment (0.2 ml/kg, 2 times per week, i.p.) and acute precipitating injury using 2 injections of 0.4 ml/kg CCl4 in combination with an i.p. challenge with Klebsiella pneumonia, mimicking a bacterial infection.

    Read original article
  • 13 July 2020

    The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology

    To access the full article published on 13 July 2020 by Trebicka et al., click on the link below.

    Read original article
  • 26 May 2020

    The DECISION consortium elects members of the Impact Board

    Today, we announce the members of the DECISION Impact Board (IB): Pierre-Emmanuel Rautou, Narsis Kiani, Marko Korenjak, Richard Moreau, Jonel Trebicka, Frank Uschner. The IB is chaired by Christian Trautwein.

    View all our advisory boards
  • 13 May 2020

    Project management talk on YouTube

    DECISION’s project manager, Dr. Mary Gazea describes the most critical aspects of the project’s governance structure and the financial issues in a confidential YouTube video. All consortium members are highly encouraged to log into the intranet (KEYWAYS) and watch her presentation. It contains very valuable information to navigate successfully through the coming project years!

  • 01 April 2020

    DECISION kicks off!

    Not an April Fool’s joke – Today, the 5.5-year long, pan-European research project begins. We are very excited to roll up our sleeves and start working!